Table 1 Characteristics of the studied participants
Variables | CVRF-No | CVRF-Yes | ||
|---|---|---|---|---|
Women (n = 531) | Men (n = 336) | Women (n = 3169) | Men (n = 2463) | |
Age, years | 47.1 ± 14.7 | 44.1 ± 16.5* | 58.6 ± 14.1† | 54.8 ± 15.1*† |
Weight, kg | 63.5 ± 9.5 | 76.6 ± 11.0* | 71.4 ± 14.7† | 85.9 ± 17.4*† |
Height, m | 1.60 ± 0.07 | 1.73 ± 0.08* | 1.58 ± 0.07† | 1.71 ± 0.08*† |
Body mass index, kg/m2 | 24.7 ± 3.1 | 25.6 ± 2.8* | 28.6 ± 5.3† | 29.2 ± 5.0*† |
Obesity, % | – | – | 36 | 40* |
Diabetes mellitus, % | – | – | 24 | 25 |
Current smoking, % | – | – | 2 | 5* |
Dyslipidemia, % | – | – | 47 | 41* |
Physical activity, % | 29 | 35 | 23† | 26† |
Alcohol use, % | 10 | 22* | 6† | 18* |
Hypertension, % | – | – | 83 | 84 |
Antihypertensive med, % | – | – | 61 | 56* |
Peripheral BP categories, % | ||||
Optimal | 49 | 28* | 17 | 15 |
Normal | 27 | 36* | 19 | 17 |
High normal | 24 | 36* | 19 | 20 |
Stage 1 hypertension | – | – | 30 | 33 |
Stage 2 hypertension | – | – | 11 | 11 |
Stage 3 hypertension | – | – | 4 | 4 |
Heart rate, b.p.m. | 73.1 ± 11.2 | 71.4 ± 11.4 | 72.7 ± 12.2 | 71.9 ± 13.0 |
Peripheral SBP, mmHg | 117.3 ± 10.7 | 122.2 ± 9.6* | 134.8 ± 19.1† | 132.8 ± 16.9*† |
Peripheral DBP, mmHg | 74.8 ± 8.4 | 77.1 ± 7.8* | 82.0 ± 12.4† | 85.5 ± 12.2*† |
Peripheral PP, mmHg | 42.5 ± 9.0 | 45.1 ± 10.1* | 52.8 ± 15.3† | 47.3 ± 13.1*† |
Peripheral MAP, mmHg | 89.0 ± 8.2 | 92.1 ± 7.0* | 99.6 ± 13.1† | 101.3 ± 12.5*† |
Central SBP, mmHg | 110.1 ± 11.2 | 113.9 ± 10.8* | 127.4 ± 19.6† | 124.9 ± 17.0*† |
Central DBP, mmHg | 76.0 ± 8.5 | 78.8 ± 7.7* | 83.3 ± 12.5† | 86.9 ± 12.3*† |
Central PP, mmHg | 34.1 ± 9.4 | 35.1 ± 10.3 | 44.1 ± 15.7† | 38.0 ± 12.7*† |
Pulse wave velocity, m/s | 6.9 ± 1.8 | 6.9 ± 1.8 | 8.8 ± 2.2† | 8.3 ± 2.0*† |
Augmentation index | 23.0 ± 10.9 | 15.0 ± 10.9* | 27.3 ± 12.4† | 17.5 ± 11.8*† |